SALEM INVESTMENT COUNSELORS INC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 84 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.

Quarter-by-quarter ownership
SALEM INVESTMENT COUNSELORS INC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2021$3,000
-25.0%
8500.0%0.00%
Q2 2021$4,0000.0%8500.0%0.00%
Q1 2021$4,000
+33.3%
8500.0%0.00%
Q4 2020$3,0000.0%8500.0%0.00%
Q3 2020$3,000
-25.0%
8500.0%0.00%
Q2 2020$4,0000.0%8500.0%0.00%
Q1 2020$4,000
+33.3%
8500.0%0.00%
Q4 2019$3,000
-57.1%
8500.0%0.00%
-100.0%
Q3 2019$7,000
-12.5%
8500.0%0.00%0.0%
Q2 2019$8,000
-46.7%
850
+70.0%
0.00%
-50.0%
Q1 2017$15,0005000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2017
NameSharesValueWeighting ↓
TANG KEVIN 240,000$1,116,00099.38%
TANG CAPITAL MANAGEMENT LLC 9,607,934$44,677,0008.98%
HealthInvest Partners AB 830,000$3,860,0005.44%
RTW INVESTMENTS, LP 2,327,903$10,825,0000.16%
GLOBEFLEX CAPITAL L P 185,598$864,0000.09%
WealthTrust Axiom LLC 25,400$118,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 82,355$383,0000.03%
FIRST MIDWEST BANK TRUST DIVISION 41,731$194,0000.02%
ACADIAN ASSET MANAGEMENT LLC 435,387$2,023,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 17,176$80,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders